AdvertisementFDA Approval Of Hepatitis C Drugs For Kids Is Likely To Speed TreatmentApril 19, 2017Michelle AndrewsfacebookEmailIn two recent clinical trials of Harvoni and Sovaldi in the treatment of young people between the ages of 12 and 17, the drugs eliminated all traces of the hepatitis C virus in 97 to 100 percent of patients, generally in 12 weeks. (TNS via Getty Images)